Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas


Low-grade serous ovarian carcinomas (LGSC) are associated with a poor response to chemotherapy and are molecularly characterized by RAS pathway activation. Using exome and whole genome sequencing, we identified recurrent mutations in the protein translational regulator EIF1AX and in NF1, USP9X, KRAS, BRAF, and NRAS RAS pathway mutations were mutually exclusive; however, we found significant co-occurrence of mutations in NRAS and EIF1AX Missense EIF1AX mutations were clustered at the N-terminus of the protein in a region associated with its role in ensuring translational initiation fidelity. Coexpression of mutant NRAS and EIF1AX proteins promoted proliferation and clonogenic survival in LGSC cells, providing the first example of co-occurring, growth-promoting mutational events in ovarian cancer. Cancer Res; 77(16); 4268-78. (c)2017 AACR.

Type Journal
ISBN 1538-7445 (Electronic) 0008-5472 (Linking)
Authors Etemadmoghadam, D.; Azar, W. J.; Lei, Y.; Moujaber, T.; Garsed, D. W.; Kennedy, C. J.; Fereday, S.; Mitchell, C.; Chiew, Y. E.; Hendley, J.; Sharma, R.; Harnett, P. R.; Li, J.; Christie, E. L.; Patch, A. M.; George, J.; Au-Yeung, G.; Mir Arnau, G.; Holloway, T. P.; Semple, T.; Pearson, J. V.; Waddell, N.; Grimmond, S. M.; Kobel, M.; Rizos, H.; Lomakin, I. B.; Bowtell, D. D. L.; deFazio, A.; Australian Ovarian Cancer Study, Group
Responsible Garvan Author (missing name)
Published Date 2017-08-15
Published Volume 77
Published Issue 16
Published Pages 4268-4278
Status Published in-print
DOI 10.1158/0008-5472.CAN-16-2224
URL link to publisher's version